SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-020025
Filing Date
2018-08-07
Accepted
2018-08-07 17:10:00
Documents
3
Period of Report
2018-08-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K crsp-8k_20180807.htm 8-K 35752
2 EX-99.1 crsp-ex991_6.htm EX-99.1 178330
3 GRAPHIC gzndbbh0ryo0000001.jpg GRAPHIC 15083
  Complete submission text file 0001564590-18-020025.txt   236104
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37923 | Film No.: 18999008
SIC: 2836 Biological Products, (No Diagnostic Substances)